APA (7th ed.) Citation

LM, C., C, W., A, E., A, K., MO, R., & RR, R. (2000). The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia (New York, N.Y.), 2(5), 426. https://doi.org/10.1038/sj.neo.7900112

Chicago Style (17th ed.) Citation

LM, Colgin, Wilkinson C, Englezou A, Kilian A, Robinson MO, and Reddel RR. "The HTERTalpha Splice Variant Is a Dominant Negative Inhibitor of Telomerase Activity." Neoplasia (New York, N.Y.) 2, no. 5 (2000): 426. https://doi.org/10.1038/sj.neo.7900112.

MLA (9th ed.) Citation

LM, Colgin, et al. "The HTERTalpha Splice Variant Is a Dominant Negative Inhibitor of Telomerase Activity." Neoplasia (New York, N.Y.), vol. 2, no. 5, 2000, p. 426, https://doi.org/10.1038/sj.neo.7900112.